4
Changes in Ownership
Tonix Pharmaceuticals Holding Corp. Filed Acc 0001144204-14-064510
Options or other derivatives
- Chief Executive Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LEDERMAN SETH · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-10-29 | Grant or award : show line 1 in the form Stock Option | +100,000 | 100,000 | D |
Loading xslF345X03/v392801_form4.xml…